Hypercalcaemia in primary squamous cell carcinoma of the stomach Sir, Dr Raju and his colleagues are to be congratul~ted on their most interesting case report of a patient with squamous cell carcinoma of the stomach and hypercalcaemia (September 1987 JRSM, p 587). Unfortunately, in their discussion they perpetuate a misconception which has dogged the hypercalcaemia literature for many years, namely that the hypercalcaemia of malignancy is due to ectopic production of parathyroid hormone (PTH) by the tumour.
There is no doubt that many cases ofhypercalcaemia associated with malignancy are humorally mediated. However, there is much evidence in the literature showing that, whatever the factor or factors may be which these tumours produce, it is immunologically (and therefore structurally) quite unlike PTH!-4. It is still unclear whether these hypercalcaemic humoral mediators are peptides, prostaglandins, leukotrienes or members of some hitherto undiscovered chemical species, but on present evidence would be quite wrong to imagine that 'pseudohyperparathyroidism' is comparable biochemically with the ectopic ACTH syndrome and related disorders. R A FISKEN
Royal Liverpool Hospital

Managing drug addiction in general practice
Sir, I read with great interest the discussion paper on this subject by Dr Martin (May 1987 JRSM, p 305). However, there are certain passages in it which could mislead other readers.
Bedford, with the contiguous town of Kempston where many drug misusers live, has a population of over 90 000. It is the county town and has substantial light industry (such as computers and chocolate factories). It is 56 miles, and less than an hour's train journey, from London (a day return ticket costs £7.00.) Ethnic minorities are numerous and varied; there are several large independent schools, and there is a prison. Dr Martin, however, describes Bedford as a 'quiet market town with a population of 77 000'.
The community psychiatric nurse (CPN), to whom Dr Martin refers, first encountered drug addiction during his training, when he worked in a psychiatric ward specializing in drug problems. Later, he cared for drug misusers in day hospitals in Yorkshire and Staffordshire. For 3 years he ran a small psychotherapy group, attended by drug misusers, before his appointment 2 years ago to his present post in Bedford, where all his time is devoted to them. Dr Martin, however, says: '... there is one community psychiatric nurse with an interest but little experience'.
One of our consultant psychiatrists admitted his first drug addict from Bedford to Fairfield Hospital when he was a registrar, in 1968, and he has continued to do so (both to Fairfield and Bedford General) since 1971, when he became a consultant. He now devotes one session a week to the problem, and to the outpatient centre for drug misusers opened by North Bedfordshire Health Authority earlier this year. This centre has a clinical assistant and the CPN, among others, on its staff.
R P RYAN
District Medical Officer North Bedfordshire Health Authority
*Dr Martin replies below:
Sir, I would agree with much of what Dr Ryan states. Bedford is a town of 70 000 inhabitants, though I am surprised that if Kempston is included the total population figure is as low as 90 000. None of our drug dependent patients comes from Kempston. I would also agree that Bedford has light industry and four prestigious public schools. It is true that many people go to London for their entertainment and the return ticket with a network card actually costs less than £6.00. We have a large but well integrated immigrant population. For many of these reasons, as I stated in my article, Bedford is a quiet town.
My statement that there is one community psychiatric nurse (CPN) with an interest but less experience was the assessment of the CPN himself, not mine. However, it is worth saying that so little was known of the prevalence of drug addiction in Bedford at the time this CPN was appointed, that during his first 6 months in post he was specifically designated as a
